MPS Limited shareholders have approved all five resolutions proposed at its 56th Annual General Meeting (AGM). The company disclosed the voting results on September 7, 2026, confirming that members passed the ordinary and special resolutions with the requisite majority.

The meeting was held via video conferencing on September 4, 2026. A total of 12,277,517 votes were polled out of 17,105,816 shares held by eligible shareholders as of the cut-off date, August 28, 2026. This represents a participation rate of 71.77%.

Resolutions Approved

Shareholders approved the adoption of the audited standalone and consolidated financial statements for FY26. The Board also secured approval for the re-appointment of Ms. Jayantika Dave as a Non-Independent Non-Executive Director and M/s. Walker Chandiok & Co LLP as Statutory Auditors for five years.

Under special business, the company appointed Mr. Atul Vohra as a Non-Independent Non-Executive Director. Additionally, shareholders passed a special resolution to re-appoint Mr. Karthik Bhat Khandige as an Independent Non-Executive Director.

Voting Breakdown

The promoter group, holding 11,690,615 shares, voted in favor of all resolutions. Public institutions and non-institutional public shareholders also largely supported the agenda items.

The Consolidated Scrutinizer's Report was issued by R. Sridharan & Associates. The report confirms compliance with Section 108 of the Companies Act, 2013, and SEBI Listing Regulations. Voting was conducted through remote e-voting and electronic voting during the AGM session.

MPS Limited delivered its most profitable year on record in FY26, with EBITDA reaching approximately ₹236 crore and a margin of 30.7%. The company’s Profit After Tax (PAT) grew by 16.3%, driving earnings per share to a record ₹102.11.

The 56th Annual General Meeting was held on September 4, 2026, via Video Conferencing. Chairman and CEO Rahul Arora highlighted that the Research business grew by approximately 17% while the Education business expanded by nearly 29%. Return on Capital Employed stood at 38.2%.

Strategic Acquisitions And Capital Allocation

The Board did not recommend a final dividend for FY26. Capital was deployed towards the acquisition of Unbound Medicine and other opportunities under evaluation. This marks a shift from the preceding eight years, during which the company returned more than ₹650 crore to shareholders.

What the Numbers Show

The decision to forgo a dividend despite record profitability underscores a strategic pivot towards organic growth via M&A. With EBITDA margins holding steady at 30.7% while PAT grew 16.3%, the operational efficiency remains robust, allowing the firm to fund acquisitions internally without diluting equity or increasing leverage significantly.

Governance And Resolutions

Shareholders approved five resolutions during the meeting. Ordinary business included adopting the audited standalone and consolidated financial statements for the year ended March 31, 2026.

Key governance appointments included:

• Re-appointment of Ms. Jayantika Dave as Non-Independent Non-Executive Director.
• Re-appointment of M/s. Walker Chandiok & Co LLP as Statutory Auditors for five years.
• Appointment of Mr. Atul Vohra as Non-Independent Non-Executive Director.
• Re-appointment of Mr. Karthik Bhat Khandige as Independent Non-Executive Director.

The Statutory Auditors’ Report and Secretarial Auditors’ Report contained no qualifications or adverse observations. The meeting concluded with e-voting results to be declared within two working days.